| Literature DB >> 31040796 |
Tadej Debevec1,2, Vincent Pialoux3,4, Grégoire P Millet5, Agnès Martin3,6, Minca Mramor7, Damjan Osredkar8.
Abstract
PURPOSE: Pre-term birth provokes life-long anatomical and functional respiratory system sequelae. Although blunted hypoxic ventilatory response (HVR) is consistently observed in pre-term infants, it remains unclear if it persists with aging and, moreover, if it influences hypoxic exercise capacity. In addition, it remains unresolved whether the previously observed prematurity-related alterations in redox balance could contribute to HVR modulation.Entities:
Keywords: exercise capacity; hypoxia; oxidative stress; pre-term birth; ventilatory response
Year: 2019 PMID: 31040796 PMCID: PMC6476987 DOI: 10.3389/fphys.2019.00437
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Baseline characteristics of the pre-term and full-term born participants.
| Pre-term born | Full-term born | |
|---|---|---|
| N | 21 | 14 |
| Age (years) | 21 ± 1 | 22 ± 2 |
| Height (cm) | 175 ± 8 | 180 ± 5∗ |
| Body mass (kg) | 69 ± 8 | 73 ± 6 |
| Body mass at birth (g) | 1264 ± 297 | 3671 ± 499∗∗ |
| Gestational age (Weeks) | 29 ± 4 | 39 ± 2∗∗ |
| BMI (kg ⋅ m2) | 22 ± 3 | 22 ± 1 |
| % Body fat | 19 ± 8 | 17 ± 5 |
| 48.5 ± 6.3 | 51.7 ± 4.5 | |
| FVC (L) [% predicted] | 5.1 ± 0.6 [97%] | 5.5 ± 0.8 [97%] |
| FEV1 (L) [% predicted] | 4.3 ± 0.6 [96%] | 4.7 ± 0.8 [98%] |
| FEV1/FVC (%) | 0.85 ± 0.06 | 0.86 ± 0.07 |
| Red blood cells (10-12 ⋅ L-1) | 5.2 ± 0.3 | 5.0 ± 0.4 |
| Hematocrit (%) | 44 ± 4 | 44 ± 4 |
| Hemoglobin (g ⋅ L-1) | 155 ± 12 | 153 ± 10 |
Figure 1Poikilocapnic hypoxic ventilatory response (HVR) at rest (Upper left panel A) and during exercise (Upper right panel B) as well as the capillary oxygen desaturation (Δ SpO2 from normoxia to hypoxia) during the resting (Lower left panel C) and exercise (Lower right panel D) parts of the hypoxia chemo-sensitivity test. Boxes depict the median and first and third interquartile ranges, with whiskers indicating maximum and minimum responses. ∗Indicates significantly different values compared to full-term born individuals (p < 0.05).
Figure 2Maximal aerobic power (MAP) of the pre-term (Panel A) and full-term (Panel B) born individuals obtained during the graded exercise test in normoxia and normobaric hypoxia (bars depict means ± SD whereas lines depict individual changes). ∗Indicates significantly different MAP values compared to full-term born individuals in both normoxia and hypoxia (p < 0.01); #Indicates significant within-group differences normoxic and hypoxic MAP values (p < 0.01).
Cardiorespiratory values and ratings of perceived exertion at rest and at volitional exhaustion during the graded exercise tests performed in normoxic (FiO2 = 0.21) and normobaric hypoxic (FiO2 = 0.13) condition.
| Normoxia | Hypoxia | |||||||
| Pre-term | Full-term | Pre-term | Full-term | |||||
|---|---|---|---|---|---|---|---|---|
| Rest | Exhaustion | Rest | Exhaustion | Rest | Exhaustion | Rest | Exhaustion | |
| SpO2 (%) | 97.1 ± 0.9 | 94.6 ± 0.5 | 97.4 ± 0.9 | 93.8 ± 0.6 | 86.7 ± 2.8 | 75.7 ± 1.2 | 87.8 ± 2.0 | 75.2 ± 1.4 |
| HR (beats ⋅ min-1) | 83 ± 14 | 183 ± 3 | 83 ± 16 | 183 ± 3 | 95 ± 12 | 182 ± 3 | 95 ± 11 | 184 ± 3 |
| / | 48.5 ± 6.3 | / | 51.7 ± 4.5 | / | 42.1 ± 7.1 | / | 45.0 ± 4.1 | |
| 13 ± 2 | 123 ± 6 | 12 ± 3 | 126 ± 5 | 17 ± 4 | 119 ± 6 | 16 ± 3 | 129 ± 7 | |
| VT (L) | 0.9 ± 0.3 | 2.70 ± 0.08 | 0.9 ± 0.3 | 2.98 ± 0.09∗ | 1.10 ± 0.24 | 2.62 ± 0.07 | 1.22 ± 0.31 | 2.75 ± 0.11 |
| fR (breaths ⋅ min-1) | 16 ± 3 | 46 ± 2 | 15 ± 4 | 43 ± 2 | 16 ± 3 | 46 ± 2 | 15 ± 4 | 48 ± 2 |
| RPEleg (a.u.) | 6.1 ± 0.2 | 19.0 ± 0.3 | 6 ± 0 | 18.6 ± 0.4 | 6.3 ± 0.8 | 18.5 ± 0.3 | 6.2 ± 0.8 | 18.1 ± 0.5 |
| RPEdys (a.u.) | 6.1 ± 0.2 | 17.3 ± 0.5 | 6.1 ± 0.2 | 17.9 ± 0.5 | 6.9 ± 1.5 | 17.6 ± 0.4 | 7.4 ± 2.0 | 18.3 ± 0.3 |
Plasma values of the measured oxidative stress and antioxidant markers obtained prior (Pre) and immediately after (Post) the hypoxia chemo-sensitivity test in both groups.
| Pre-term | Full-term | |||
|---|---|---|---|---|
| Pre | Post | Pre | Post | |
| AOPP (μmol ⋅ L-1) | 153 ± 81 | 162 ± 86 | 143 ± 65 | 128 ± 36 |
| MDA (μmol ⋅ L-1) | 12.1 ± 3.5 | 13.8 ± 7.8 | 10.9 ± 4.1 | 9.7 ± 2.8 |
| Nitrotyrosine (μmol ⋅ L-1) | 39 ± 25 | 34 ± 22 | 40 ± 25 | 46 ± 37 |
| SOD (mol ⋅ L-1 ⋅ min-1) | 15.0 ± 4.1 | 15.2 ± 4.8 | 12.9 ± 3.8 | 13.1 ± 3.7 |
| FRAP (μmol ⋅ L-1) | 568 ± 105 | 585 ± 147 | 557 ± 85 | 563 ± 147 |
| GPX (mol ⋅ L-1 ⋅ min-1) | 96 ± 18 | 92 ± 17 | 96 ± 12 | 107 ± 31 |
| Catalase (μmol⋅L-1 ⋅ min-1) | 1.02 ± 0.72 | 0.91 ± 0.56 | 1.01 ± 0.47 | 0.85 ± 0.46 |